Loading open roles.
Loading open roles.
Alchemab Therapeutics is developing natural protective antibodies designed to keep people free of hard-to-treat diseases. The company is building their transformative engine to identify drug targets and develop a pipeline of antibody therapeutics for hard-to-treat cancers, neurodegenerative conditions, and infectious diseases. Alchemab Therapeutics was established in 2019 by Uri Laserson and Jane
Roles are read from Alchemab Therapeutics’s Bamboohr every hour and disappear here as soon as they close there.